tiprankstipranks
Advertisement
Advertisement

RDHL Stock Latest News

RedHill Biopharma Secures Up to $19.4 Million in Private Placement to Fund Pipeline and Potential Acquisition
Company AnnouncementsRedHill Biopharma Secures Up to $19.4 Million in Private Placement to Fund Pipeline and Potential Acquisition
3d ago
6K
RDHL
RedHill Biopharma announces $19.4M private placement
PremiumThe Fly
RedHill Biopharma announces $19.4M private placement
3d ago
RDHL
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
PremiumMarket News
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
5d ago
GILD
JAZZ
RedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst
PremiumMarket News
RedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst
11d ago
GILD
RDHL
RedHill Biopharma Wins FDA Rare Pediatric Disease Designation for Opaganib in Neuroblastoma
PremiumCompany Announcements
RedHill Biopharma Wins FDA Rare Pediatric Disease Designation for Opaganib in Neuroblastoma
12d ago
6K
RDHL
RedHill Biopharma’s opaganib granted FDA Rare Pediatric Disease designation
PremiumThe FlyRedHill Biopharma’s opaganib granted FDA Rare Pediatric Disease designation
12d ago
RDHL
RedHill Biopharma Moves to Enforce $10.9 Million New York Judgment Against Kukbo in Korea
Premium
Company Announcements
RedHill Biopharma Moves to Enforce $10.9 Million New York Judgment Against Kukbo in Korea
13d ago
6K
RDHL
RedHill Biopharma launches enforcement of $11M judgment against Kukbo
Premium
The Fly
RedHill Biopharma launches enforcement of $11M judgment against Kukbo
13d ago
RDHL
RedHill Biopharma advancing opaganib options for Ebola outbreak biodefense
PremiumThe Fly
RedHill Biopharma advancing opaganib options for Ebola outbreak biodefense
19d ago
RDHL
RedHill Biopharma Moves to Advance Opaganib as Oral Antiviral Option for Current Ebola Outbreak
PremiumCompany Announcements
RedHill Biopharma Moves to Advance Opaganib as Oral Antiviral Option for Current Ebola Outbreak
19d ago
6K
RDHL
RedHill Biopharma Expands At-The-Market ADS Offering to Boost Capital Flexibility
PremiumCompany Announcements
RedHill Biopharma Expands At-The-Market ADS Offering to Boost Capital Flexibility
25d ago
6K
RDHL
RedHill Biopharma Reports Promising MAP-Killing Data for Next-Generation Crohn’s Candidate RHB-204
PremiumCompany Announcements
RedHill Biopharma Reports Promising MAP-Killing Data for Next-Generation Crohn’s Candidate RHB-204
2M ago
6K
RDHL
RedHill Biopharma’s RHB-204 shows efficacy in Crohn’s Disease
PremiumThe FlyRedHill Biopharma’s RHB-204 shows efficacy in Crohn’s Disease
2M ago
RDHL
RedHill Biopharma Reshapes Talicia Franchise and Strengthens Balance Sheet in 2025 Results
Premium
Company Announcements
RedHill Biopharma Reshapes Talicia Franchise and Strengthens Balance Sheet in 2025 Results
2M ago
6K
RDHL
RedHill Biopharma announces presentation of preclinical data on opaganib at AACR
Premium
The Fly
RedHill Biopharma announces presentation of preclinical data on opaganib at AACR
2M ago
RDHL
RedHill Biopharma Showcases New Opaganib Preclinical Data in Neuroblastoma and Triple-Negative Breast Cancer at AACR 2026
PremiumCompany Announcements
RedHill Biopharma Showcases New Opaganib Preclinical Data in Neuroblastoma and Triple-Negative Breast Cancer at AACR 2026
2M ago
6K
RDHL
RedHill Biopharma Receives Nasdaq Minimum Bid Price Deficiency Notice
PremiumCompany Announcements
RedHill Biopharma Receives Nasdaq Minimum Bid Price Deficiency Notice
2M ago
6K
RDHL
RedHill Biopharma Shareholders Approve RSU Grants and Share Capital Increase
PremiumCompany Announcements
RedHill Biopharma Shareholders Approve RSU Grants and Share Capital Increase
4M ago
6K
RDHL
RedHill and Cumberland Begin Joint U.S. Commercial Launch of Talicia
PremiumCompany Announcements
RedHill and Cumberland Begin Joint U.S. Commercial Launch of Talicia
4M ago
6K
RDHL
RedHill Biopharma announces full sales and operational launch of Talicia
PremiumThe FlyRedHill Biopharma announces full sales and operational launch of Talicia
4M ago
CPIX
RDHL
RedHill Biopharma Calls March 5 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
Premium
Company Announcements
RedHill Biopharma Calls March 5 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
5M ago
6K
RDHL
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
Premium
Company Announcements
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
5M ago
6K
RDHL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >